Auna (AUNA) Resumen de Acciones
Auna S.A., proveedor de servicios sanitarios, gestiona hospitales y clínicas en México, Perú y Colombia. Saber más
| Puntuación del snowflake | |
|---|---|
| Valoración | 5/6 |
| Crecimiento futuro | 3/6 |
| Rendimiento pasado | 1/6 |
| Salud financiera | 2/6 |
| Dividendos | 0/6 |
Recompensas
Análisis de riesgos
AUNA Community Fair Values
Create NarrativeSee what 11 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Competidores de Auna S.A.
Historial de precios y rendimiento
| Precios históricos de las acciones | |
|---|---|
| Precio actual de la acción | US$4.31 |
| Máximo en las últimas 52 semanas | US$6.97 |
| Mínimo de 52 semanas | US$4.17 |
| Beta | 1.03 |
| Cambio en 1 mes | -17.27% |
| Variación en 3 meses | -18.37% |
| Cambio de 1 año | -35.19% |
| Variación en 3 años | n/a |
| Variación en 5 años | n/a |
| Variación desde la OPV | -55.10% |
Noticias y actualizaciones recientes
Actualización de narrativa • May 04
AUNA: Execution On 2026 Guidance Will Drive Reassessment Of Bearish Reset
Analysts have reduced their price target on Auna from $19.00 to $9.00, citing updated assumptions for discount rate, revenue growth, profit margins, and a lower future P/E following recent bearish Street research. Analyst Commentary Even with the lower headline target, some bullish analysts still see room for upside if Auna can deliver on key execution milestones and support the revised valuation assumptions.
Actualización de narrativa • Apr 19
AUNA: Mexico Execution And 2026 Guidance Will Support Bullish Re‑Rating
Analysts have maintained their price target on Auna at $7.20, citing a mix of more cautious and more optimistic research views that reflect slightly updated assumptions for discount rates, growth and P/E multiples. Analyst Commentary Bullish Takeaways Bullish analysts point to the current $7.20 target as reasonable relative to their updated P/E assumptions, suggesting the valuation still lines up with their expectations for the business model and capital allocation.Recent updates
Actualización de narrativa • May 04
AUNA: Execution On 2026 Guidance Will Drive Reassessment Of Bearish Reset
Analysts have reduced their price target on Auna from $19.00 to $9.00, citing updated assumptions for discount rate, revenue growth, profit margins, and a lower future P/E following recent bearish Street research. Analyst Commentary Even with the lower headline target, some bullish analysts still see room for upside if Auna can deliver on key execution milestones and support the revised valuation assumptions.Actualización de narrativa • Apr 19
AUNA: Mexico Execution And 2026 Guidance Will Support Bullish Re‑Rating
Analysts have maintained their price target on Auna at $7.20, citing a mix of more cautious and more optimistic research views that reflect slightly updated assumptions for discount rates, growth and P/E multiples. Analyst Commentary Bullish Takeaways Bullish analysts point to the current $7.20 target as reasonable relative to their updated P/E assumptions, suggesting the valuation still lines up with their expectations for the business model and capital allocation.Actualización de narrativa • Apr 05
AUNA: Mexico Execution And 2026 Guidance Will Support Long-Term Upside
Analysts have trimmed their price target for Auna from about $10.42 to $7.20, reflecting updated views on discount rates, revenue growth, profit margins and future P/E, following a mix of recent bullish and bearish research updates. Analyst Commentary Recent research on Auna shows a mix of optimism and caution, which helps explain the reduced price target and the current debate around the shares.
Actualización de narrativa • Mar 22
AUNA: Mixed Research Views And 2026 Guidance Will Shape Execution Outlook
Auna's analyst price target has been updated to $6.00, with analysts citing mixed recent research that includes a more cautious stance from BTG Pactual, along with more constructive views from HSBC and Jefferies on the company outlook. Analyst Commentary Recent Street research on Auna points to a split view, with some analysts turning more constructive while others are sounding more cautious and adjusting ratings and price targets accordingly.Actualización de narrativa • Mar 08
AUNA: Execution On Mixed Research Views Will Shape Future Upside Potential
Analysts have trimmed their Auna price target to $6.00, reflecting slightly adjusted assumptions around the discount rate, revenue growth, profit margins and future P/E after a mix of more cautious and more constructive recent research views. Analyst Commentary Recent research views on Auna have moved in different directions, with some firms turning more constructive and at least one becoming more cautious.Actualización de narrativa • Feb 22
AUNA: Execution On Mixed Mexico Expansion Views Will Drive Future Upside
Analysts have nudged their price target on Auna up from $6.00 to $6.50, reflecting mixed but generally constructive research, with one firm turning more cautious even as others highlight potential for slightly better growth, margins, and a lower assumed future P/E. Analyst Commentary Recent research has not been uniformly positive, and some bearish analysts are clearly leaning more cautious on Auna, even as others highlight potential upside.Actualización de narrativa • Feb 07
AUNA: Mexico Expansion And Leverage Execution Will Drive Upside Potential
Analysts have reduced their price target on Auna to $6.00 from $13.50, reflecting a more cautious stance as they weigh concerns about a slower ramp up in Mexico, elevated leverage, and mixed recent rating changes from BTG Pactual, HSBC, and Jefferies. Analyst Commentary Recent research shows a split in views on Auna, with some firms taking a more constructive stance while others highlight execution and balance sheet risks.Actualización de narrativa • Jan 24
AUNA: Mexico Execution And Leverage Path Will Shape Balanced Upside Potential
Analysts have lifted their Auna price target to $6.00 from $6.00, keeping the fair value level steady while adjusting their view to reflect updated assumptions on discount rates, revenue growth, profit margins and future P/E in light of mixed but generally constructive recent research. Analyst Commentary Recent research on Auna has been mixed, with some firms taking a more constructive stance while others highlight ongoing execution and balance sheet questions.Artículo de análisis • Jan 23
Does Auna (NYSE:AUNA) Have A Healthy Balance Sheet?
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Actualización de narrativa • Jan 10
AUNA: Mexico Expansion Will Reframe Perceived Execution And Leverage Risks
Analysts have trimmed their price target on Auna to US$6 from US$13.50, pointing to a slower ramp-up in Mexico, a less supportive consolidated growth profile, and expectations that leverage will remain elevated. Analyst Commentary Recent Street research on Auna has turned more cautious, with JPMorgan cutting its rating to Neutral and lowering its price target to US$6 from US$13.50.Actualización de narrativa • Dec 22
AUNA: Mexico Execution And Deleveraging Will Drive Long-Term Upside Potential
Analysts have trimmed their price target on Auna by roughly $0.25 to reflect a slightly lower fair value estimate and a modestly higher discount rate, citing concerns over slower than expected growth and sustained leverage highlighted in recent research. Analyst Commentary Analyst reactions to the latest developments at Auna have focused on the trade off between long term growth optionality and near term execution risks, particularly around the company's regional expansion and balance sheet trajectory.Actualización de narrativa • Dec 08
AUNA: Mexico Expansion And Deleveraging Will Unlock Future Upside Potential
Analysts have lowered their price target on Auna from $13.50 to $6.00, citing a slower than expected ramp-up in Mexico, a less compelling consolidated growth profile, and persistently elevated leverage. Analyst Commentary Analyst views on Auna have turned more cautious following the recent downgrade and target price cut to $6.00, but the stock’s reset valuation is also seen as creating a more balanced risk reward profile.Actualización de narrativa • Nov 24
AUNA: Future Expansion Plans In Mexico Will Unlock Growth Potential
Narrative Update: Analyst Price Target Change for Auna The average analyst price target for Auna was reduced from $12.08 to $10.67. Analysts point to a slower than expected operational ramp-up and persistent elevated leverage as key factors for the adjustment.Artículo de análisis • Nov 14
Auna (NYSE:AUNA) Is Looking To Continue Growing Its Returns On Capital
Did you know there are some financial metrics that can provide clues of a potential multi-bagger? Firstly, we'd want to...Seeking Alpha • Jun 23
Auna: Scalable, Profitable, Misunderstood
Summary AUNA's integrated LatAm healthcare platform is undervalued due to short-term execution, not structural flaws. The payor-provider model drives superior margins, cost efficiencies, and creates a powerful ecosystem with strong operating leverage, especially in underutilized Mexican assets. Management is actively addressing physician onboarding and payor mix, with insurance-led strategies poised to drive patient volume and profitability recovery. Despite risks, AUNA's discounted valuation, robust growth, and leading margins make it a compelling Buy at current levels. Read the full article on Seeking AlphaNueva narrativa • May 29
High-Efficiency Healthcare Model And Demographic Trends Will Shape Future Landscape
Operational challenges in Mexico are being addressed, while strong performance in Peru showcases the potential of Auna's value-based, integrated care model.Artículo de análisis • Jan 29
A Piece Of The Puzzle Missing From Auna S.A.'s (NYSE:AUNA) 26% Share Price Climb
The Auna S.A. ( NYSE:AUNA ) share price has done very well over the last month, posting an excellent gain of 26%. While...Artículo de análisis • Jan 19
Here's Why Auna (NYSE:AUNA) Has A Meaningful Debt Burden
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Seeking Alpha • Jan 15
Auna: Cheap Entry Level In Latin American Healthcare Play
Summary Auna is a leading player in the Spanish-speaking Latin America medical industry, focusing particularly on high-complexity diseases, such as cancer. Most SSLA have a highly fragmented and underserved healthcare market, and populations are becoming elderly, demanding more and better services. AUNA stock has been impacted negatively following its IPO process, as local institutional players such as pension funds overbought the stock and had to sell due to regulatory limits. AUNA stock trades currently below 6X EV / EBITDA, while revenues and EBITDA are growing at double digits. Patient investors should benefit from valuation normalization metrics and continued growth. Though it still has high leverage (Net Debt / EBITDA =3.7), it has been able to decrease it (from 6.8X in 2021) and has stable and growing operating cash flows (annual run rate USD250MM last quarter). Interest rate reductions should benefit the company. Read the full article on Seeking AlphaRentabilidad de los accionistas
| AUNA | US Healthcare | Mercado US | |
|---|---|---|---|
| 7D | -10.2% | -0.4% | 1.0% |
| 1Y | -35.2% | 16.3% | 28.7% |
Rentabilidad vs. Industria: Los resultados de AUNA fueron inferiores a los de la industria US Healthcare, que obtuvo un rendimiento del 16.3% el año pasado.
Rentabilidad vs. Mercado: AUNA obtuvo unos resultados inferiores a los del mercado US, que fueron del 28.7% el año pasado.
Volatilidad de los precios
| AUNA volatility | |
|---|---|
| AUNA Average Weekly Movement | 7.2% |
| Healthcare Industry Average Movement | 7.6% |
| Market Average Movement | 7.2% |
| 10% most volatile stocks in US Market | 16.4% |
| 10% least volatile stocks in US Market | 3.1% |
Precio estable de las acciones: AUNA no ha tenido una volatilidad de precios significativa en los últimos 3 meses en comparación con el mercado US.
Volatilidad a lo largo del tiempo: La volatilidad semanal de AUNA (7%) se ha mantenido estable durante el año pasado.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 1989 | 15,025 | Suso Zamora Leon | www.aunainvestors.com |
Auna S.A., proveedor de servicios sanitarios, gestiona hospitales y clínicas en México, Perú y Colombia. La empresa ofrece asistencia sanitaria prepagada, seguros dentales y oftalmológicos y planes oncológicos. También vende medicamentos.
Resumen de fundamentos de Auna S.A.
| Estadísticas fundamentales de AUNA | |
|---|---|
| Capitalización bursátil | US$324.92m |
| Beneficios(TTM) | US$20.09m |
| Ingresos (TTM) | US$1.32b |
15.9x
Ratio precio-beneficio (PE)0.2x
Ratio precio-ventas (PS)¿Está AUNA sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de AUNA | |
|---|---|
| Ingresos | S/4.52b |
| Coste de los ingresos | S/2.81b |
| Beneficio bruto | S/1.71b |
| Otros gastos | S/1.64b |
| Beneficios | S/68.74m |
Últimos beneficios comunicados
Mar 31, 2026
Próxima fecha de beneficios
n/a
| Beneficios por acción (BPA) | 0.93 |
| Margen bruto | 37.89% |
| Margen de beneficio neto | 1.52% |
| Ratio deuda/patrimonio | 193.6% |
¿Cómo se ha desempeñado AUNA a largo plazo?
Ver rendimiento histórico y comparativaAnálisis de la empresa y estado de los datos financieros
| Datos | Última actualización (huso horario UTC) |
|---|---|
| Análisis de la empresa | 2026/05/22 16:21 |
| Precio de las acciones al final del día | 2026/05/22 00:00 |
| Beneficios | 2026/03/31 |
| Ingresos anuales | 2025/12/31 |
Fuentes de datos
Los datos utilizados en nuestro análisis de empresas proceden de S&P Global Market Intelligence LLC. Los siguientes datos se utilizan en nuestro modelo de análisis para generar este informe. Los datos están normalizados, lo que puede introducir un retraso desde que la fuente está disponible.
| Paquete | Datos | Marco temporal | Ejemplo Fuente EE.UU. * |
|---|---|---|---|
| Finanzas de la empresa | 10 años |
| |
| Estimaciones del consenso de analistas | +3 años |
|
|
| Precios de mercado | 30 años |
| |
| Propiedad | 10 años |
| |
| Gestión | 10 años |
| |
| Principales avances | 10 años |
|
* Ejemplo para valores de EE.UU., para no EE.UU. se utilizan formularios y fuentes normativas equivalentes.
A menos que se especifique lo contrario, todos los datos financieros se basan en un periodo anual, pero se actualizan trimestralmente. Esto se conoce como datos de los últimos doce meses (TTM) o de los últimos doce meses (LTM). Más información.
Modelo de análisis y copo de nieve
Los detalles del modelo de análisis utilizado para generar este informe están disponibles en nuestra página de Github, también tenemos guías sobre cómo utilizar nuestros informes y tutoriales en Youtube.
Conozca al equipo de talla mundial que diseñó y construyó el modelo de análisis Simply Wall St.
Métricas industriales y sectoriales
Simply Wall St calcula cada 6 horas nuestras métricas sectoriales y de sección. Los detalles de nuestro proceso están disponibles en Github.
Fuentes analistas
Auna S.A. está cubierta por 8 analistas. 7 de esos analistas presentaron las estimaciones de ingresos o ganancias utilizadas como datos para nuestro informe. Las estimaciones de los analistas se actualizan a lo largo del día.
| Analista | Institución |
|---|---|
| Samuel Campos Alves | BTG Pactual |
| Leandro Bastos | Citigroup Inc |
| Leandro Bastos | Citigroup Inc |